Clinical trials: open to volunteers, sponsored by BeiGene
Waldenstrom Macroglobulinemia
Observational Study Evaluating the Efficacy and Safety of Zanubrutinib in Participants With Waldenström Macroglobulinemia
This is a hybrid (retrospective and prospective) non-interventional registry study to further describe the clinical profile of zanubrutinib in Waldenström macroglobulinemia (WM) participants with and without specific mutations…
- Trial name
- NCT05640102
- Testing
- Zanubrutinib
- Where
- 8 sites in United States, Puerto Rico
- Volunteers
- 111 people
- Sponsor
- BeiGene
MSI-H/dMMR Solid Tumors
Tislelizumab (Anti-Programmed Cell Death Protein-1 (PD-1) Antibody) in MSI-H or dMMR Solid Tumors
In this Phase 2, Single-Arm, Multi-Center, Open-Label Study, participants with previously treated locally advanced unresectable or metastatic solid tumors with mismatched repair deficient (dMMR) or microsatellite instability-high…
- Trial name
- NCT03736889
- Testing
- Tislelizumab (BGB-A317)
- Where
- 30 sites in China
- Volunteers
- 200 people
- Sponsor
- BeiGene